Johnson & Johnson Archives

J&J’s Invokana reduces risk of renal failure in high-risk diabetes patients

https://pharmaphorum.com/news/jjs-invokana-reduces-risk-of-renal-failure-in-high-risk-diabetes-patients/

J&J gets US okay for first targeted bladder cancer drug

https://pharmaphorum.com/news/jj-gets-us-okay-for-first-targeted-bladder-cancer-drug/

3rd annual Advanced R&D Sourcing & Procurement Summit 2019

https://pharmaphorum.com/events/3rd-annual-advanced-rd-sourcing-procurement-summit-2019/

Bayer and J&J settle Xarelto lawsuits in US

https://pharmaphorum.com/news/bayer-and-jj-settle-xarelto-lawsuits-in-us/

NICE backs interim funding for J&J/Takeda myeloma regimen

https://pharmaphorum.com/news/nice-backs-interim-funding-for-jj-takeda-myeloma-regimen/

Reimagining the future of healthcare

https://deep-dive.pharmaphorum.com/magazine/pharma-research-rare-diseases/johnson-innovation-william-hait/

Bayer files prostate cancer drug darolutamide in Japan

https://pharmaphorum.com/news/bayer-files-prostate-cancer-drug-darolutamide-in-japan/

Bayer/Orion showcase results from prostate cancer challenger

https://pharmaphorum.com/news/bayer-orion-showcase-results-from-prostate-cancer-challenger/

Janssen’s esketamine depression drug set for key panel vote

https://pharmaphorum.com/news/janssens-esketamine-depression-drug-set-for-key-panel-vote/

Search